Two Seas Capital LP - 31 Mar 2025 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

Filing Manager
Two Seas Capital LP
Reporting Manager
Two Seas Capital LP
Security
Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share
Symbol
ADAP
Shares outstanding
1,539,726,375 shares
Disclosed Ownership
123,178,110 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 09:00:51 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
Next filing
13 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Two Seas Capital LP 8% 123,178,110 123,178,110 0 /s/ Sina Toussi Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner
Two Seas Capital GP LLC 8% 123,178,110 123,178,110 0 /s/ Sina Toussi Sina Toussi / Managing Member
Sina Toussi 8% 123,178,110 123,178,110 0 /s/ Sina Toussi Sina Toussi / Self